International Biotechnology Trust PLC Vera Therapeutics, Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 758,355 shares of VERA stock, worth $32.1 Million. This represents 3.53% of its overall portfolio holdings.
Number of Shares
758,355
Previous 975,227
22.24%
Holding current value
$32.1 Million
Previous $15.7 Million
33.57%
% of portfolio
3.53%
Previous 4.88%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$182 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$167 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$141 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$125 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$118 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.14B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...